Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 117,484 | 75,505 | 105,684 | 122,424 | 104,685 |
| Cost of Goods | 29,993 | 22,305 | 29,732 | 31,904 | 22,304 |
| Gross Profit | 87,491 | 53,200 | 75,952 | 90,520 | 82,381 |
| Operating Expenses | 70,864 | 60,652 | 59,590 | 89,711 | 80,272 |
| Operating Income | 17,620 | -7,147 | 17,094 | 1,713 | 2,413 |
| Interest Expense | 7,132 | 5,456 | 6,022 | 5,996 | 5,940 |
| Other Income | -4,338 | 5,292 | -2,515 | 742 | -2,289 |
| Pre-tax Income | 6,150 | -7,311 | 8,557 | -3,541 | -5,816 |
| Income Tax | -123,969 | -42 | 398 | 1,347 | 271 |
| Net Income Continuous | 130,119 | -7,269 | 8,159 | -4,888 | -6,087 |
| Net Income | $130,119 | $-7,269 | $8,159 | $-4,888 | $-6,087 |
| EPS Basic Total Ops | 3.03 | -0.17 | 0.19 | -0.12 | -0.15 |
| EPS Basic Continuous Ops | 3.03 | -0.17 | 0.19 | -0.12 | -0.15 |
| EPS Diluted Total Ops | 2.94 | -0.17 | 0.19 | -0.11 | -0.15 |
| EPS Diluted Continuous Ops | 2.94 | -0.17 | 0.19 | -0.12 | -0.15 |
| EBITDA(a) | $28,716 | $1,946 | $25,948 | $10,767 | $11,914 |